To investigate whether FoxM1 expression might be associated with the progression of ccRCC, the FoxM1 expression levels and the clinic pathologic characteristics of 83 patients with ccRCC were compared by immunohistochemistry. This evidence concerns the gene FOXM1 and nonpapillary renal cell carcinoma.